Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, January 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 956 followers.

Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary ... https://t.co/fq9ZaHGbhk

Immunotherapy combing MABs and PD -L - part of the solution. https://t.co/XhPWssC7RT https://t.co/XhPWssC7RT

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.